1994
DOI: 10.1136/jcp.47.3.257
|View full text |Cite
|
Sign up to set email alerts
|

Neutrophil cytoplasmic antibodies (p-ANCA) in ulcerative colitis.

Abstract: p-ANCA in ulcerative colitis have a different immunoglobulin subclass distribution than the ANCA of systemic necrotising vasculitis and necrotising and crescentic glomerulonephritis. This may point to differences in immune regulation between these diseases. Both cathepsin G and lactoferrin are recognised by a subpopulation of ulcerative colitis p-ANCA. In our series, eight out of 36 (22%) of ulcerative colitis associated p-ANCA react with lactoferrin and seven (19.5%) other sera with cathepsin G. None of them … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
26
0

Year Published

1996
1996
2014
2014

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 53 publications
(26 citation statements)
references
References 24 publications
0
26
0
Order By: Relevance
“…Granulocytes were obtained from fresh human blood using LymphoprepÔ (Nycomed Pharma AS, Oslo, Norway) density gradient centrifugation and further isolated as described by Ellerbroek et al 27 Freshly isolated granulocytes were used for further experiments as described next. The isolated granulocytes were CD15 1 and CD45 low + as determined by flow cytometric analysis.…”
Section: Cell Isolation and Culturementioning
confidence: 99%
“…Granulocytes were obtained from fresh human blood using LymphoprepÔ (Nycomed Pharma AS, Oslo, Norway) density gradient centrifugation and further isolated as described by Ellerbroek et al 27 Freshly isolated granulocytes were used for further experiments as described next. The isolated granulocytes were CD15 1 and CD45 low + as determined by flow cytometric analysis.…”
Section: Cell Isolation and Culturementioning
confidence: 99%
“…As yet, the antigens that stimulate p-ANCA production are poorly defined. Nonetheless, evidence suggests that lactoferrin (but not myeloperoxidase [7,29]) may be a major target antigen for the p-ANCA of inflammatory bowel disease [27][28][29][30][31]. Walmsley et al [32] detected serum anti-lactoferrin antibodies in only 2 of 52 patients with ulcerative colitis, but in another study, immunoglobulin G anti-lactoferrin antibodies were found in the sera from 50 % of patients with ulcerative colitis and\or PSC [29].…”
Section: Discussionmentioning
confidence: 92%
“…Indeed, high plasma lactoferrin concentrations have been reported in active rheumatoid arthritis and systemic lupus erythematosus [60] -conditions also associated with the presence of serum anti-neutrophil antibodies [61,62]. In inflammatory bowel disease, approximately 22-89 % of patients with ulcerative colitis [4,7,28,29,[31][32][33][34][35][36][37][38] and up to 34 % of patients with Crohn's disease [4,28,[32][33][34]36,41,63] are p-ANCA positive. As yet, the antigens that stimulate p-ANCA production are poorly defined.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…1,2 Inflammatory bowel conditions are associated with rare atypical P-ANCAs, against cathepsin G, elastase, and bacterial permeability increasing proteins. 9,10 The Case 1 photomicrograph (Figure 1b) perhaps illustrates an atypical P-ANCA, which could be due to the presence of atypical antigens. Recently, ulcerative colitis patients have been described to have PR3-ANCA.…”
Section: Discussionmentioning
confidence: 99%